Stéphanie Katz – Research Scientist II – Novartis Institutes for BioMedical Research (NIBR) | LinkedIn
Die besten Biotech-Aktien 2022 | Die besten Aktien | Online Broker LYNX
Stéphanie Katz – Research Scientist II – Novartis Institutes for BioMedical Research (NIBR) | LinkedIn
Partner
Microorganisms | Free Full-Text | The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019 | HTML
Water | Free Full-Text | Integrated Water Resources Management and Policy Integration: Lessons from 169 Years of Flood Policies in Switzerland | HTML
Specification of the plastic templates included in the Kato-Katz kits... | Download Table
Biotechnische Regulierung der Kohlmottenschildlaus in Kohlgemüse – Sachstand und Perspektiven | SpringerLink
Pharma & Biotech - BWT
Partner
Marianne Jossen (@Eulorama) / Twitter
Microorganisms | Free Full-Text | The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019 | HTML
Unternehmer aus Überzeugung - Kanton Aargau
PDF) Microarray-based genetic identification of beneficial organisms as a new tool for quality control of laboratory cultures
Unsere Partner: Ein Netzwerk für neueste Technologien | Hightech Zentrum Aargau
Erfahrungsbericht des Start-ups Exquiron Biotech AG - business parc
New formulation: beneficial nematodes in capsules
Pharma & Biotech - BWT
Biotechnische Regulierung der Kohlmottenschildlaus in Kohlgemüse – Sachstand und Perspektiven | SpringerLink